• To learn about the benefits of medicines optimisation in older people living with multimorbidity and frailty
• To understand how the multidisciplinary team can work together to optimise a patient’s medicines and reduce polypharmacy
• To familiarise yourself with a seven-step process for reviewing a patient’s medicines
Medicines optimisation involves ensuring that medicines are administered safely and effectively. In the UK, an ageing population and an increasing prevalence of polypharmacy mean that interprofessional medicines reviews and medicines optimisation are vital. This article uses a case study of an older person living with frailty to provide a critical analysis of the medicines optimisation process in optimising health outcomes. The case study focuses on the medicines prescribed, the issues that can arise such as polypharmacy, and the benefits of a medicines-optimisation approach.
Nursing Older People. doi: 10.7748/nop.2021.e1326
Peer reviewThis article has been subject to external double-blind peer review and checked for plagiarism using automated software
Correspondence Conflict of interestNone declared
Lyne S, McEwan C (2021) Benefits of medicines optimisation for older people living with frailty. Nursing Older People. doi: 10.7748/nop.2021.e1326
Published online: 24 March 2021
or
Alternatively, you can purchase access to this article for the next seven days. Buy now
Are you a student? Our student subscription has content especially for you.
Find out more
